Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Vandetanib-d6

Vandetanib-d6 is the deuterium labeled Vandetanib. Vandetanib (D6474) is a potent, orally active inhibitor of VEGFR2/KDR tyrosine kinase activity (IC50=40 nM) . Vandetanib also has activity versus the tyrosine kinase activity of VEGFR3/FLT4 (IC50=110 nM) and EGFR/HER1 (IC50=500 nM) [1].

Product Specifications

CAS Number

1174683-49-8

Product Name Alternative

ZD6474-d6

UNSPSC

12352005

Hazard Statement

H302-H360-H373-H410

Target

Apoptosis; Autophagy; Isotope-Labeled Compounds; VEGFR

Type

Isotope-Labeled Compounds

Related Pathways

Apoptosis; Autophagy; Others; Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Solubility

10 mM in DMSO

Smiles

FC1=CC(Br)=CC=C1NC2=NC=NC3=CC(OCC4CCN(CC4)C([2H])([2H])[2H])=C(C=C23)OC([2H])([2H])[2H]

Molecular Formula

C22H18D6BrFN4O2

Molecular Weight

481.39

Precautions

P260-P264-P270-P273-P280-P330-P391-P405-P501

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Wedge SR, et al. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 2002 Aug 15;62 (16) :4645-55.|[3]Hegedus C, et al. Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: implications for the emergence and reversal of cancer drug resistance. Biochem Pharmacol. 2012 Aug 1;84 (3) :260-7.|[4]Takeda H, et al. Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency. Exp Cell Res. 2013 Feb 15;319 (4) :417-23.|[5]Inoue K, et al. Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice. Clin Cancer Res. 2012 Jul 15;18 (14) :3924-33.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

MAPK14 (CPTC-MAPK14-1), 1mg/mL
BNUM2228-50 1x 50 µL

MAPK14 (CPTC-MAPK14-1), 1mg/mL

Sign In for Pricing
View Details
Human C11orf83 (UQCC3) activation kit by CRISPRa
GA119059 1 Kit

Human C11orf83 (UQCC3) activation kit by CRISPRa

Sign In for Pricing
View Details
Wdr17 Mouse Gene Knockout Kit (CRISPR)
KN519340 1 Kit

Wdr17 Mouse Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Nkiras1 (NM_023526) Mouse Tagged ORF Clone
MG201849 10 µg

Nkiras1 (NM_023526) Mouse Tagged ORF Clone

Sign In for Pricing
View Details
Pgp9.5 (UCHL-1) (UCHL1/841), CF640R conjugate, 0.1mg/mL
BNC400841-500 1x 500 µL

Pgp9.5 (UCHL-1) (UCHL1/841), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
PLK1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI6C6]
TA500401AM 100 µL

PLK1 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI6C6]

Sign In for Pricing
View Details